Reishi dual extract — three method comparison on the same starting material
Same lot of Ganoderma lucidum fruit body, three extraction methods side-by-side. Beta-glucan and triterpene yields differed enough to change which method we recommend for which product type. Ratios and method specs below.
The setup
Reishi is the textbook example of why "mushroom extract" is a phrase that hides a lot. The two principal active fractions are immune-modulatory β-glucans (water-extractable polysaccharides) and anti-inflammatory triterpenes (the ganoderic acids — alcohol-extractable lipophilic molecules). A pure water extract gets one; a pure alcohol extract gets the other. A dual extract gets both, but the ratios depend heavily on method.
Took 1 kg of cultivated G. lucidum fruit body from a single lot (USDA-organic, Wisconsin grower we audit annually). Ground to ~1mm particle size. Split into three 250 g portions. Ran three different dual-extraction methods. Tested all three end products on the same lab, same week.
Method 1 — Sequential (water first, then alcohol)
Hot-water extraction at 92°C for 2 hours, filtered, marc dried. Marc then alcohol-extracted (75% ethanol) at room temp for 7 days, filtered. Two fractions concentrated separately and recombined 1:1.
Yield: 18.4% of starting dry mass. β-glucan: 28.3% of extract by Megazyme. Triterpene: 4.1% by HPLC (sum of ganoderic acids A, B, C, D, F, K). Notable: best β-glucan extraction efficiency. The water phase isn't competing with anything for substrate.
Method 2 — Sequential (alcohol first, then water)
Same starting mass, reverse order. Alcohol extraction first (75% ethanol, 7 days RT), filtered, marc dried. Marc then hot-water extracted at 92°C for 2 hours, filtered. Recombined 1:1.
Yield: 16.9% of starting dry mass. β-glucan: 22.7% of extract. Triterpene: 5.8% of extract. Notable: best triterpene yield. Alcohol going first cleanly extracts the lipophilic fraction before water disrupts the cell walls. Lower β-glucan because some polysaccharide ends up in the alcohol fraction (gets dropped during alcohol concentration).
Method 3 — Simultaneous (50/50 ethanol-water)
Single-stage extraction with a 50/50 ethanol/water solvent system, 75°C for 4 hours, single filtration, single concentration step.
Yield: 17.1% of starting dry mass. β-glucan: 24.8% of extract. Triterpene: 4.6% of extract. Notable: middle-of-the-road on both fractions. Operationally simpler — one solvent, one extraction, one filter, one concentrate — at the cost of slightly lower efficiency on both targets. Probably the right choice if you're running small batches and labor is your binding constraint.
What we recommend now
For an immune-forward reishi product where β-glucan content is the headline number: method 1 (water-first sequential).
For an inflammation-forward product where triterpenes drive the use case: method 2 (alcohol-first sequential).
For a small-batch operation with limited equipment: method 3 (simultaneous) is fine — you give up ~5 percentage points on either fraction but save half the labor.
The takeaway most relevant to consumers: when a reishi product reports its β-glucan and triterpene percentages, those numbers reflect a method choice, not a fixed property of reishi. A 28% β-glucan / 4% triterpene product and a 23% β-glucan / 6% triterpene product are both legitimate "dual extracts" of the same fruit body — they just emphasize different fractions.
Updating the OMGX reishi product spec to method 1 (we'd been on method 3 for operational simplicity). Will update the COA template to break out triterpene class separately so the data is more legible to consumers.
Goes deeper in
Long-form articles on the science
More from lab notes
Apr 22
CBDA tincture — 90-day room-temp stability check
Pulled three samples from the September batch and compared COAs at day 0, 45, and 90. CBDA-to-CBD conversion sits at 8% over 90 days at 22°C / amber glass / no light. That's the number we needed before talking about a CBDA-specific product line.
Mar 28
Q1 2026 heavy-metal screen — six suppliers, two failures
Routine quarterly screen across our six current mushroom-extract suppliers. Two failed the cadmium spec. Both are out of the supply chain pending re-test. Why this matters even when the numbers look small.
Read next
Most recent dispatches across both streams.
April blue oyster bag run — 14% contam, three lessons
Ran 21 supplemented hardwood bags across two flushes. 3 contaminated, 18 fruited. Below the typical 8-12% target but instructive — and the contamination pattern points at one specific moment in the workflow.
CBDA tincture — 90-day room-temp stability check
Pulled three samples from the September batch and compared COAs at day 0, 45, and 90. CBDA-to-CBD conversion sits at 8% over 90 days at 22°C / amber glass / no light. That's the number we needed before talking about a CBDA-specific product line.
Lion's mane fruiting chamber — rebuilt around the CO2 problem
Lion's mane has a real fruiting-stage CO2 sensitivity that doesn't show up in oyster or king trumpet runs. Tore out the old chamber, rebuilt with a switched intake fan + CO2 monitor + scheduled exchange. First post-rebuild flush coming in next week.
Shiitake 3782 — getting cold-shock timing right
The 3782 strain wants cold water, but how cold and for how long is the kind of question every guide handwaves. Logged five flushes on a single block under different shock protocols. Sweet spot is narrower than I expected.